drugset / Trial / NCT05752123
A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.
Terminated
2 enrolled
EdiGene (GuangZhou) Inc.
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open label, single site study to evaluate the safety and Efficacy of ET-01 Transplantation in subjects with Transfusion Dependent β-Thalassaemia.
Timeline
- Start
- 2023-02-18
- Primary completion
- 2024-01-29
- Completion
- 2025-03-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | Intravenous |